Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa

TY - JOUR

T1 - Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa

AU - Fischer, Peter U.

AU - King, Christopher L.

AU - Jacobson, Julie A.

AU - Weil, Gary J.

N1 - Funding Information: This work was supported by a grant of the Bill & Melinda Gates Foundation (GH5342). The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The funders advised on the design of the study, had no role in data collection and analysis, had no role in decision to publish, and contributed in the writing of the manuscript. We would like to thank the Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Project technical advisory team for helpful discussions regarding the use of IDA.

PY - 2017/1/5

Y1 - 2017/1/5

UR - https://www.scopus.com/pages/publications/85012884237

U2 - 10.1371/journal.pntd.0005163

DO - 10.1371/journal.pntd.0005163

M3 - Article

C2 - 28056015

AN - SCOPUS:85012884237

SN - 1935-2727

VL - 11

JO - PLoS neglected tropical diseases

JF - PLoS neglected tropical diseases

IS - 1

M1 - e0005163

ER -